Resultados de la búsqueda 261-270 of 10489 for Cycle

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   On the second part of this study, patients will receive the remainder of the chemotherapy cycles (interim maintenance I, delayed intensification, interim ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   On the second part of this study, patients will receive the remainder of the chemotherapy cycles (interim maintenance I, delayed intensification, interim ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   On the second part of this study, patients will receive the remainder of the chemotherapy cycles (interim maintenance I, delayed intensification, interim ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant ...

5. Salud de la mujer Women's life stages - Mayo Clinic

   Evaluation of the menstrual cycle and timing of ovulation. https://www.uptodate.com/contents/search. Accessed Aug. 30, 2022. Hoffman BL, et al. Menopausal ...

6. Neurocirugía - Ensayos clínicos

   ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

7. Neurología - Ensayos clínicos

   ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

8. Ensayos clínicos - Neurología

   The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study ...

9. Neurología - Ensayos clínicos - Mayo Clinic

   ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

10. Neurocirugía - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...